CGM Toolbox: Expert Resource for Continuous Glucose Monitoring in Diabetes Practice
By
Supported by an independent educational grant from Abbott Diabetes Care.
Summary
This article appears to be a resource page for healthcare professionals about continuous glucose monitoring (CGM) in diabetes care. It features disclosures from Davida F. Kruger, a certified nurse practitioner at Henry Ford Health, listing her financial relationships with numerous diabetes and medical device companies including Abbott, Dexcom, Insulet, Lilly, Medtronic, Novo Nordisk, and others. The page is positioned as a bookmarkable resource for gaining expert insights on using CGM in clinical practice.
Source
Key quotes
· 2 pulledBookmark this page and come back often to gain insights from diabetes experts on how to successfully use continuous glucose monitoring in your practice.
Davida F. Kruger, MSN, APN-BC, BC-ADM, Certified Nurse Practitioner, Henry Ford Health Division of Endocrinology, Diabetes, Bone, and Mineral Disease, Detroit, Michigan
You might also wanna read
Understanding Continuous Glucose Monitoring for Type 1 Diabetics
Continuous glucose monitoring is a technology that measures blood glucose levels frequently, primarily beneficial for type 1 diabetics. The
Personal Reflection on Using Proprietary Medical Devices for Diabetes Management
The article discusses the author's personal experience with diabetes and their difficult choice to use a proprietary continuous glucose moni
Samsung Galaxy Watch Glucose Monitoring: A Guide to CGM Apps and Their Limitations
A practical guide comparing methods for displaying continuous glucose monitor (CGM) data on Samsung Galaxy Watches. It covers official apps
GlycemicGPT: Open-Source AI-Powered Diabetes Management Platform (Alpha)
GlycemicGPT is an open-source diabetes management platform that leverages AI-powered analysis to help individuals track and manage their dia
MIT Develops Noninvasive Glucose Monitoring Device Using Raman Spectroscopy
MIT researchers have developed a noninvasive device using Raman spectroscopy to measure blood glucose levels without finger pricks. The shoe
Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows
This article from Verge's Optimizer newsletter examines how health tech companies are marketing products specifically to GLP-1 drug users (p
Comments
Sign in to join the conversation.
No comments yet. Be the first.
